Bisphosphonate prescribing, persistence and cumulative exposure in Ontario, Canada

por Burden, A. M., Paterson, J. M., Solomon, D. H., Mamdani, M., Juurlink, D. N., Cadarette, S. M.
Publicado 2011

A159 OPIOID USE IS DECLINING AMONG PEOPLE WITH INFLAMMATORY BOWEL DISEASE: A POPULATION-BASED STUDY

por Kuenzig, E, Mason, J, Bernstein, C N, Gomes, T, Juurlink, D, Kaplan, G G, Peña-Sánchez, J, Targownik, L E, Vigod, S, Begum, J, Nugent, Z, Benchimol, E I
Publicado 2022

A162 CHRONIC OPIOID THERAPY IS ASSOCIATED WITH INCREASED HEALTH SERVICES UTILIZATION AND DIRECT HEALTHCARE COSTS: A POPULATION-BASED STUDY

por Kuenzig, E, Mason, J, Bernstein, C N, Gomes, T, Juurlink, D, Kaplan, G G, Peña-Sánchez, J, Targownik, L E, Vigod, S, Begum, J, Nugent, Z, Benchimol, E I
Publicado 2022

Treatment for calcium channel blocker poisoning: A systematic review

por St-Onge, M., Dubé, P.-A., Gosselin, S., Guimont, C., Godwin, J., Archambault, P. M., Chauny, J.-M., Frenette, A. J., Darveau, M., Le sage, N., Poitras, J., Provencher, J., Juurlink, D. N., Blais, R.
Publicado 2014